Dexcom Operating Ltd is a limited company established in 2015, specializing in the design, development, and commercialization of continuous glucose monitoring (CGM) technology. Based in London, UK, the company focuses on providing a simplified and accurate method for managing diabetes. Dexcom’s core product, the Dexcom Continuous Glucose Monitoring system, delivers real-time glucose readings directly to the patient’s fingertips, eliminating the need for fingersticks or scanning. The company’s primary service is to enhance diabetes management through innovative technology. Dexcom’s device offers continuous glucose monitoring, providing valuable insights into blood sugar levels. The system’s design prioritizes user convenience and improved patient outcomes. Dexcom operates internationally, with a growing presence in key markets. As a limited company, Dexcom is registered with the Financial Conduct Authority (FCA) under SIC code - 32500, indicating a focus on the manufacture of medical and dental instruments and supplies. The company’s size estimate is relatively small, reflecting its specialized technological focus. Dexcom’s international business mobility strategy indicates a commitment to global expansion. The company’s key focus is on streamlining diabetes management through a user-friendly and reliable technology.

Dexcom Operating Ltd is a limited company established in 2015, specializing in the design, development, and commercialization of continuous glucose monitoring (CGM) technology. Based in London, UK, the company focuses on providing a simplified and accurate method for managing diabetes. Dexcom’s core product, the Dexcom Continuous Glucose Monitoring system, delivers real-time glucose readings directly to the patient’s fingertips, eliminating the need for fingersticks or scanning. The company’s primary service is to enhance diabetes management through innovative technology. Dexcom’s device offers continuous glucose monitoring, providing valuable insights into blood sugar levels. The system’s design prioritizes user convenience and improved patient outcomes. Dexcom operates internationally, with a growing presence in key markets. As a limited company, Dexcom is registered with the Financial Conduct Authority (FCA) under SIC code - 32500, indicating a focus on the manufacture of medical and dental instruments and supplies. The company’s size estimate is relatively small, reflecting its specialized technological focus. Dexcom’s international business mobility strategy indicates a commitment to global expansion. The company’s key focus is on streamlining diabetes management through a user-friendly and reliable technology.